1. At a Glance – Oxygen Hai, Valuation ICU Mein
Linde India is that rare Indian company which literally sells oxygen and still manages to make investors breathless. With a market cap of ₹55,710 Cr, a Q3 FY26 quarterly revenue of ₹701 Cr, and a PAT of ₹192 Cr, the company is printing margins like it owns the periodic table. Operating margin? 37%. Debt? Practically missing at ₹67 Cr. Promoter holding? A rock-solid 75% by the BOC Group, UK.
But before you light the celebratory incense sticks—this stock trades at a P/E of 95x and EV/EBITDA of ~55x. That’s not valuation, that’s a wedding premium. The stock has delivered 12.6% returns in 3 months, 8.6% in 1 year, while earnings quietly grew much faster.
So what’s happening here? Is this a monopoly oxygen supplier with annuity cash flows, or a fully priced aristocrat where even good news needs permission? Let’s put on the EduInvesting detective hat and open the oxygen cylinder slowly.
2. Introduction – The Most Boring Business That Became Sexy
Industrial gases are not exactly dinner-table conversation. No one flexes at a party saying, “Bro I invested in argon.” And yet, Linde India has quietly become one of the most elite, monopoly-like businesses in Indian manufacturing.
Founded decades ago and now majority-owned by the global BOC Group, Linde India sits at the intersection of steel, oil & gas, healthcare, electronics, and now renewables. When steel plants expand, Linde gets paid. When hospitals need oxygen, Linde gets paid. When semiconductor fabs need ultra-high purity gases, Linde gets paid again—this time in designer margins.
Despite modest 5–7% sales CAGR, profits have compounded much faster due to operating leverage and asset sweating. This is not a “growth at any cost” company. This is a “sign a 20-year contract and chill” company.
But the market has already crowned it king. The question is—has the coronation already happened before the kingdom expanded?
3. Business Model – WTF Do They Even Do?
Imagine running a business where:
- Customers sign 10–20 year contracts
- Switching suppliers is a logistical nightmare
- Your product is mission-critical (oxygen tends to be important for living)
- Pricing is stable and inflation-friendly
Welcome to Linde India.
Segment 1: Gases, Related Products & Services (65% of FY25 Revenue)
This is the cash cow. Linde operates 26 gas plants across India supplying:
- On-site gases via pipelines to steel, glass, chemical giants
- Merchant bulk gases via cryogenic tankers
- Packaged gases in cylinders for smaller industries
Key gases include oxygen, nitrogen, argon, helium, carbon dioxide, xenon, krypton—basically everything your chemistry textbook warned you about.
On-site supply is the real moat. Once Linde installs a plant inside or next to a customer’s facility, that relationship is stickier than Fevicol. Steel majors like Tata Steel, SAIL, JSW, Vedanta don’t casually change oxygen vendors.
Segment 2: Project Engineering Division (PED) – 35% of FY25 Revenue
PED designs and builds:
- Air Separation Units (ASUs)
- Nitrogen plants
- PSA systems
- Cryogenic vessels
- Turnkey
